| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.078 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.058 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.054 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.031 | 0.6 |